Market cap | $206.20M |
---|---|
Enterprise value | $364.73M |
Revenue | CAD$158.296M |
---|---|
EBITDA | -CAD$146.55 |
Income | -CAD$1.75 |
Revenue Q/Q | -1.61% |
Revenue Y/Y | N/A |
P/E | N/A |
---|---|
Forward P/E | -31.17 |
EV/Sales | 3.02 |
EV/EBITDA | N/A |
EV/EBIT | N/A |
PEG | N/A |
Price/Sales | 1.29 |
P/FCF | N/A |
Price/Book | 4.99 |
Book/Share | 1.15 |
Cash/Share | 3.50 |
FCF yield | -66.42% |
Volume | 665.520k / N/A |
---|---|
Relative vol. | N/A |
EPS | N/A |
---|---|
EPS Q/Q | 160.00% |
Est. EPS Q/Q | -80.00% |
Profit margin | -854.00% |
---|---|
Oper. margin | -108.05% |
Gross margin | -1.90% |
EBIT margin | -108.05% |
EBITDA margin | -92.58% |
Ret. on assets | -145.20% |
---|---|
Ret. on equity | -245.44% |
ROIC | -13.14% |
ROCE | -26.30% |
Debt/Equity | 1.83 |
---|---|
Net debt/EBITDA | 3.13 |
Current ratio | 4.08 |
Quick ratio | 3.29 |
Volatility | 6.68% |
---|---|
Beta | 1.32 |
RSI | 41.62 |
---|
Insider ownership | 0.10% |
---|---|
Inst. ownership | 25.69% |
Shares outst. | 54.546M |
---|---|
Shares float | 0.000 0.00% |
Short % of float | N/A |
Short ratio | 2.73 |
Dividend | N/A |
---|---|
Dividend yield | N/A |
Payout ratio | N/A |
Payment date | N/A |
Ex-dividend date | N/A |
Earnings date | 20 Jun 2024 |
Monday, 25 March 2024
|
|
Navigating Regulatory Changes: 10 Cannabis ETFs To Explore | |
Thursday, 22 February 2024
|
|
12 Best Marijuana Stocks To Invest In | |
Monday, 5 February 2024
|
|
15 Most Common Addictions In The US | |
Saturday, 27 January 2024
|
|
18 Best 52-Week Low Stocks To Buy Now | |
Friday, 29 December 2023
|
|
11 Cheap Pot Stocks to Buy | |
Wednesday, 27 December 2023
|
|
12 Most Profitable Pot Stocks Now | |
Sunday, 10 December 2023
|
|
Could Aurora Cannabis Be a Screaming Buy Right Now? | |
Saturday, 9 December 2023
|
|
2 Popular Stocks to Avoid Like the Plague in 2024 and Beyond | |
Wednesday, 6 December 2023
|
|
Is Aurora Cannabis Stock a Buy Now? | |
Thursday, 30 November 2023
|
|
Where Will Aurora Cannabis Be in 5 Years? | |
Saturday, 11 November 2023
|
|
Aurora Cannabis Inc. Q2 2024 Earnings Call Transcript | |
Thursday, 9 November 2023
|
|
Aurora Cannabis Q2 2024 Earnings Call Transcript | |
Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA | |
Wednesday, 11 October 2023
|
|
Canada Legalized Marijuana 5 Years Ago. Why Is the Industry Now in Such Bad Shape? | |
Sunday, 1 October 2023
|
|
3 Things About Aurora Cannabis That Smart Investors Know | |
Thursday, 28 September 2023
|
|
Why Aurora Cannabis Stock Got Smoked Today | |
2 Cheap Cannabis Stocks to Avoid in October | |
Powered by
Robintrack.
Insider | Age | Since | Compensation |
---|---|---|---|
Michael Singer (56) Executive Chairman of the Board since 2020 | 56 | 2020 | $2,860,100 |
Glen Ibbott | 2017 | $2,346,120 | |
Allan Cleiren | 2017 | $1,780,770 | |
Miguel Martin (49) CEO and Director | 49 | $1,687,057 | |
Jillian Swainson | 2019 | $1,658,460 | |
Ronald Funk (63) Lead Independent Director since 2019 | 63 | 2019 | $332,735 |
Margaret Atkins (63) Independent Director since 2019 | 63 | 2019 | $322,735 |
Andre Jerome | $312,211 | ||
Adam Szweras (48) Independent Director since 2015 | 48 | 2015 | $307,735 |
Norma Beauchamp (59) Independent Director since 2018 | 59 | 2018 | $307,735 |
Lance Friedmann (65) Independent Director since 2020 | 65 | 2020 | $99,579 |
Michael Detlefsen (57) Independent Director since 2020 | 57 | 2020 | $99,569 |
Jonathan Page | 2018 | ||
Miguel Martin (48) Chief Executive Officer and Director since 2020 | 48 | 2020 | |
Nathalie Clark | |||
Dave Aird | |||
Alex Miller | |||
John Barnet | |||
Lori Schick | |||
Carey Squires | |||
Michelle Lefler | |||
Ananth Krishnan | |||
Dr. Jonathan Page Ph.D. (51) Chief Science Officer | 51 | ||
Darryl Vleeming | |||
Allan John Cleiren C.P.A., C.A., ICD.D. | |||
Michael Singer (55) Exec. Chairman | 55 |
aurora is a canadian company and licensed producer of artisanal medical marijuana pursuant to the marihuana for medical purposes regulations. we ensure the highest quality, reliability, and safety of our products through advanced cultivation techniques carried out in our 55,200 square foot expandable state-of-the-art production facility in alberta, canada. aurora’s wholly-owned subsidiary, australis capital inc., seeks to be an active participant in the u.s. cannabis market.
- Health Care > Pharmaceuticals
- Aurora Cannabis Inc, 500 - 10355 Jasper Avenue, Edmonton T5J 1Y6, Canada
- 855 279 4652
- Investor relations
Quarterly EPS estimates
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions CAD) | 10 Feb 2023 | 29 Sep 2022 | |
---|---|---|---|
Current assets | |||
Cash | CAD$250.206363 | CAD$369.278 | |
Short term investments | CAD$30.185539 | CAD$0.375 | |
Net receivables | CAD$46.188688 | CAD$45.941 | |
Inventory | CAD$101.314939 | CAD$146.242 | |
Other current assets | CAD$30.185539 | CAD$114.595 | |
Total current assets | CAD$524.570628 | CAD$681.826 | |
Long term investments | CAD$464.896347 | CAD$1.237 | |
Property, plant & equipment | CAD$307.886895 | CAD$317.8 | |
Goodwill | CAD$18.200815 | CAD$18.75 | |
Intangible assets | CAD$77.840304 | CAD$102.141 | |
Other assets | CAD$46.794641 | CAD$48.173 | |
Total assets | CAD$989.466976 | CAD$1,169.927 | |
Current liabilities | |||
Accounts payable | CAD$18.206 | ||
Short long term debt | CAD$30.319873 | CAD$33.168 | |
Other current liabilities | CAD$98.275511 | CAD$32.426 | |
Total current liabilities | CAD$128.595384 | CAD$167.633 | |
Long term debt | CAD$188.170122 | CAD$250.691 | |
Other liabilities | CAD$81.858729 | CAD$121.734 | |
Minority interest | CAD$34.953915 | CAD$38.042 | |
Total liabilities | CAD$449.409274 | CAD$575.43 | |
Stockholders' equity | |||
Common stock | CAD$428.101306 | CAD$6,764.621 | |
Retained earnings | -CAD$6,008.080086 | -CAD$6,150.25 | |
Treasury stock | -CAD$57.916 | ||
Capital surplus | |||
Total stockholder equity | CAD$540.057702 | CAD$556.455 | |
Net tangible assets | CAD$444.016583 | CAD$435.564 |
(in millions CAD) | 2022 | 2021 | ||
---|---|---|---|---|
Current assets | ||||
Cash | CAD$446.791786 | CAD$421.457 | ||
Short term investments | CAD$30.953246 | CAD$3.751 | ||
Net receivables | CAD$47.814081 | CAD$56.482 | ||
Inventory | CAD$118.121485 | CAD$137.721 | ||
Other current assets | CAD$30.953246 | CAD$35.312 | ||
Total current assets | CAD$758.107798 | CAD$665.892 | ||
Long term investments | CAD$345.147565 | CAD$0.289 | ||
Property, plant & equipment | CAD$237.534088 | CAD$598.278 | ||
Goodwill | CAD$887.737 | |||
Intangible assets | CAD$71.928169 | CAD$375.263 | ||
Other assets | CAD$34.457272 | CAD$77.272 | ||
Total assets | CAD$1,103.255363 | CAD$2,604.731 | ||
Current liabilities | ||||
Accounts payable | CAD$14.099533 | CAD$13.277 | ||
Short long term debt | CAD$33.57923 | CAD$34.749 | ||
Other current liabilities | CAD$100.080432 | CAD$18.359 | ||
Total current liabilities | CAD$147.759195 | CAD$116.375 | ||
Long term debt | CAD$240.608759 | CAD$293.182 | ||
Other liabilities | CAD$38.077285 | CAD$92.043 | ||
Minority interest | CAD$0.519906 | |||
Total liabilities | CAD$429.877027 | CAD$567.031 | ||
Stockholders' equity | ||||
Common stock | CAD$281.836389 | CAD$6,424.296 | ||
Retained earnings | -CAD$6,143.516778 | -CAD$4,321.085 | ||
Treasury stock | -CAD$65.511 | |||
Capital surplus | ||||
Total stockholder equity | CAD$673.378337 | CAD$2,037.7 | ||
Net tangible assets | CAD$601.450168 | CAD$774.7 |
Income statement
(in millions CAD) | 10 Feb 2023 | 29 Sep 2022 | |
---|---|---|---|
Revenue | |||
Total revenue | CAD$59.608563 | CAD$49.263 | |
Cost of revenue | CAD$57.563593 | CAD$44.871 | |
Gross profit | CAD$2.04497 | CAD$4.392 | |
Operating activities | |||
Research & development | CAD$1.243798 | CAD$1.603 | |
Selling, general & administrative | CAD$38.933682 | CAD$42.18 | |
Total operating expenses | CAD$108.202701 | CAD$95.073 | |
Operating income | -CAD$48.594137 | -CAD$45.81 | |
Income from continuing operations | |||
Net other income | -CAD$18.054 | ||
EBIT | -CAD$48.591238 | -CAD$45.81 | |
Income before tax | -CAD$65.022516 | -CAD$63.864 | |
Income tax expense | -CAD$0.09471 | -CAD$11.977 | |
Minority interest | CAD$38.042 | ||
Net income | |||
Net income | -CAD$64.927806 | -CAD$51.604 | |
Income (for common shares) | -CAD$64.927806 | -CAD$51.604 |
(in millions CAD) | 2022 | 2021 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | CAD$225.196742 | CAD$245.252 | ||
Cost of revenue | CAD$216.420399 | CAD$266.81 | ||
Gross profit | CAD$8.776344 | -CAD$21.558 | ||
Operating activities | ||||
Research & development | CAD$10.570071 | CAD$11.447 | ||
Selling, general & administrative | CAD$178.291226 | CAD$174.635 | ||
Total operating expenses | CAD$469.025664 | CAD$522.309 | ||
Operating income | -CAD$243.828922 | -CAD$277.057 | ||
Income from continuing operations | ||||
Net other income | -CAD$422.741 | |||
EBIT | -CAD$243.828922 | -CAD$277.057 | ||
Income before tax | -CAD$1,750.100166 | -CAD$699.798 | ||
Income tax expense | -CAD$2.178316 | -CAD$6.321 | ||
Minority interest | CAD$0.511 | |||
Net income | ||||
Net income | -CAD$1,747.92185 | -CAD$693.625 | ||
Income (for common shares) | -CAD$1,747.92185 | -CAD$693.625 |
Cash flows
(in millions CAD) | 10 Feb 2023 | 29 Sep 2022 | |
---|---|---|---|
Net income | -CAD$64.927806 | -CAD$51.604 | |
Operating activities | |||
Depreciation | CAD$11.901227 | CAD$9.959 | |
Change in accounts receivable | CAD$46.188688 | CAD$6.444 | |
Changes in inventory | CAD$101.314939 | -CAD$0.236 | |
Total cash flows from operations | -CAD$58.943356 | -CAD$31.138 | |
Investing activities | |||
Capital expenditures | -CAD$2.968044 | -CAD$5.555 | |
Investments | |||
Other cash flows from investing | -CAD$2.399 | ||
Total cash flows from investing | CAD$13.570186 | -CAD$41.931 | |
Financing activities | |||
Dividends paid | |||
Net borrowings | -CAD$61.901907 | -CAD$1.537 | |
Other cash flows from financing | -CAD$8.097 | ||
Total cash flows from financing | -CAD$60.389466 | -CAD$9.634 | |
Effect of exchange rate | CAD$14.174 | ||
Change in cash and equivalents | CAD$250.206363 | -CAD$68.529 |
(in millions CAD) | 2022 | 2021 | ||
---|---|---|---|---|
Net income | -CAD$1,747.92185 | -CAD$693.625 | ||
Operating activities | ||||
Depreciation | CAD$95.292411 | CAD$91.892 | ||
Change in accounts receivable | -CAD$11.727038 | CAD$7.371 | ||
Changes in inventory | -CAD$6.198288 | CAD$8.451 | ||
Total cash flows from operations | -CAD$111.752379 | -CAD$210.577 | ||
Investing activities | ||||
Capital expenditures | -CAD$32.774444 | -CAD$53.082 | ||
Investments | CAD$18.064 | |||
Other cash flows from investing | -CAD$4.675 | |||
Total cash flows from investing | -CAD$37.237906 | -CAD$26.905 | ||
Financing activities | ||||
Dividends paid | ||||
Net borrowings | -CAD$203.557043 | -CAD$122.92 | ||
Other cash flows from financing | -CAD$21.152 | |||
Total cash flows from financing | CAD$150.354657 | CAD$521.954 | ||
Effect of exchange rate | -CAD$25.194 | |||
Change in cash and equivalents | -CAD$3.206615 | CAD$259.278 |
Recent institutional transactions
Quarter | Shareholder | Change |
Shares owned
Shares
|
Value (in thousands USD) |
---|---|---|---|---|
2024 Q1 | Mirae Asset Global Investments Co |
Opened
|
2,298,350 | $1,557,592 |
2024 Q1 | Hrt Financial L.P. |
Opened
|
182,845 | $802 |
2024 Q1 | Two Sigma Investments, L.P. |
Opened
|
140,143 | $615,228 |
2024 Q1 | Parallax Volatility Advisers, L.P. |
Opened
|
130,522 | $572,992 |
2024 Q1 | Morgan Stanley |
Opened
|
127,067 | $557,824 |
2024 Q1 | Dimensional Fund Advisors L.P. |
Opened
|
86,288 | $378,805 |
2024 Q1 | Two Sigma Advisers, L.P. |
Opened
|
78,053 | $342,653 |
2024 Q1 | Simplex Trading |
Opened
|
67,801 | $297 |
2024 Q1 | Bank Of Montreal can/ |
Opened
|
40,687 | $194,727 |
2024 Q1 | Centiva Capital, L.P. |
Opened
|
38,333 | $168,282 |
Institutional shareholders
Shareholder | Stake |
Shares owned
Shares
|
Value (in thousands USD) |
---|---|---|---|
Etf Managers Group | 19.44% | 10,601,833 | |
Renaissance Technologies | 18.88% | 10,299,979 | |
Mirae Asset Global Investments Co | 9.06% | 4,943,017 | |
Millennium Management | 5.73% | 3,128,148 | |
D. E. Shaw & Co | 4.89% | 2,664,650 | |
Two Sigma Investments, L.P. | 3.31% | 1,806,439 | |
Yong Rong (hk) Asset Management Ltd | 2.75% | 1,500,000 | |
Axs Investments | 2.07% | 1,127,362 | |
Morgan Stanley | 1.99% | 1,085,474 | |
Dimensional Fund Advisors L.P. | 1.74% | 949,207 |